(Hypertension. 1997;29:1156-1164.)
© 1997 American Heart Association, Inc.
Articles |
1D- and
1B-Adrenergic Receptor Expression
From the Departments of Physiology (M.L.C., J.E.F.) and Vascular Surgery (A.J.B.), The University of North Carolina, Chapel Hill.
| Abstract |
|---|
|
|
|---|
1-adrenergic receptor subtypes on
arterial and venous vessels, together with evidence for
altered
-adrenergic receptor expression in hypertension, led us to
examine whether mechanical load influences expression of
1B -and
1D-adrenergic receptors in rat
aortic smooth muscle cells (SMCs). We used RNase protection and
radioligand binding assays to measure mRNA and
1-adrenergic receptor density. In the first model, SMCs
were subjected to phasic loading using flexible culture plates. As a
positive control for the load stimulus, postconfluent, quiescent
passage 5 cells demonstrated the expected load-dependent morphological
realignment. However, no changes were detected in expression of either
1D- or
1B-adrenergic receptor mRNAs or
receptor density after 24 to 48 hours of loading. ß-Actin and
SMC-specific
-actin mRNA, as well as cell number and per-cell total
RNA and protein, were also unaffected. In a second model, intact
thoracic aortas, in either the presence or absence of
endothelial cells, were cultured for 48 hours under
tonic load. Like cultured cells, 48 hours of load did not
affect SMC expression of
1-adrenergic receptor mRNAs. We
used suprarenal aortic coarctation to examine effects of increased
pressure in vivo. As with the previous in vitro and in situ models,
hypertension (30 days) had no effect on expression of
1B- and
1D-adrenergic receptor mRNAs in
the suprarenal aorta compared with sham coarctation. To separate
pressure per se from humoral influences, we also measured mRNAs in the
subrenal, normotensive aorta.
1B mRNA levels decreased
to 68±14% of sham-coarcted controls in subrenal aorta exposed to
normal blood pressure but also to systemic humoral changes induced by
coarctation. As a positive control for a load effect, SMC-specific
-actin mRNA increased for loaded aorta in organ culture and in
hypertensive aorta in vivo, whereas expression of ß-actin mRNA was
unaffected. These results from cell culture, organ culture, and in vivo
models suggest that pressure (load) alone has no effect on
1B- and
1D-adrenergic receptor
expression. In coarctation hypertension, smooth muscle protected from
the hypertension showed a decline in
1B mRNA that may be
due to a humoral factor or factors.
Key Words: muscle, smooth, vascular receptors, adrenergic, alpha gene expression growth
| Introduction |
|---|
|
|
|---|
1-Adrenergic receptors (ARs) on smooth muscle cells
(SMCs) mediate sympathetic regulation of peripheral
resistance by small arteries/arterioles (resistance vessels) and venous
return by venules/veins (capacitance vessels). We have previously shown
in rat skeletal muscle that arteriole
1-AR constriction,
which appears to be mediated by the
1D subtype (see
Graham et al1 for a description of the nomenclature for
1-ARs used in this article), is inhibited by reduced
blood flow and tissue oxygen, whereas venule
1
constriction, which is mediated by the
1B subtype, is
unaffected.2 3 These segment-specific differences in
subtype expression and local modulation, if generalizable, may underlie
the well-known metabolic antagonism of adrenergic
constriction of resistance but not capacitance vessels that serves to
optimize autoregulation of tissue oxygen while at the same time
preserving reflex control of venous return.4 Although to
date few other vessels have been examined, a similar differential
1-AR subtype distribution mediates constriction of rat
thoracic aorta (
1D)5 6 7 versus vena cava
(
1B).8 However, little is known concerning
the factor or factors that might direct differential expression of
these
1-AR subtypes by vascular smooth muscle of
arteries and veins.
A major physical factor in the vascular SMC microenvironment that could
influence expression of
1D-ARs by arterial
and
1B-ARs by venous SMCs is the artery-to-vein
intravascular pressure gradient that imposes a different mechanical
load on SMCs in the two regions. Also congruent with the hypothesis
that mechanical load may modulate expression of
1-ARs
are reports that
1-AR density is increased in
some9 10 but not all11 12 13 14 models of
hypertension. In addition, an increase in cardiac myocyte
1-AR density has been observed in the
pressure-overloaded failing ventricle in guinea pigs.15
However, no studies have identified whether pressure or mechanical
loading of muscle cells per se can induce changes in
-AR expression,
owing to the difficulty in isolating pressure from other factors
present in vivo.
Unlike many cells, vascular SMCs are exposed to phasic and tonic changes in pressure-dependent mechanical loading of the vascular wall. Moreover, increases in pressure-induced stretch of SMCs induces myogenic contraction, which is a key physiological regulator of vascular smooth muscle tone. The cellular signaling mechanisms underlying myogenic tone include increases in intracellular calcium, activation of protein kinase C, and phosphorylation of contractile and regulatory proteins. Past studies have demonstrated that SMCs respond to cyclic mechanical loading in vitro with increases in DNA synthesis and expression of platelet-derived growth factor (PDGF) isoform genes.16 Also, cardiac myocytes subjected to cyclic mechanical loading in vitro increase expression of c-fos17 as well as increase protein synthesis18 and myelin basic protein activity.19 Recent studies have proposed the presence of shear stress mechanosensitive elements in the promoters of several genes. For example, bovine aortic endothelial cells and epithelial-like HeLa cells exhibit shear stressinduced gene expression of monocyte chemotactic protein-1, which is dependent on the presence of a region in the promoter.20 Moreover, a specific 6-bp putative shear stress response element has been localized to several endothelial cell genes, including the PDGF B-chain promoter.21 Although the importance of such elements in SMCs is unclear, SMCs are optimized to physiologically detect and respond to alterations in mechanical load with changes in contractile activity and may also possess load-sensitive mechanisms to alter expression of adrenergic receptors.
In the present study, we examined the hypothesis that mechanical
load directly modulates expression of
1B- and/or
1D-ARs using measurements of cellular mRNA content and
1-AR density. Because load may also influence SMC
growth16 and affect interpretations of these measurements,
we also determined cell proliferation,
-actin, ß-actin, cellular
RNA, and protein as controls for an effect of load on growth and
non
1-AR gene expression. Indeed, to our knowledge only
one study22 has examined the effect of SMC load per se on
SMC growth. We used three models to isolate mechanical loading of SMCs
from other factors. Load applied over 48 hours was examined in rat
aortic SMCs cultured in vitro on flexible bottom culture plates and
also maintained in situ in intact aortic organ culture. In a third
model, we used prolonged hypertension produced for 30 days by
suprarenal abdominal aortic coarctation to study the effect of
increased mechanical load in vivo.
| Methods |
|---|
|
|
|---|
Application of Load to Cultured Cells
SMCs were seeded onto collagen-coated flexible membrane bottom
plates (Flex). To favor the differentiated phenotype and
quiescence, we studied passage 5 cells 4 days after they had reached
confluence.24 25 26 A separate cell line was used in each
experimental replicate. Aortic SMCs were subjected to 24 or 48 hours of
cyclic stretch (1 Hz) and compared with time-matched control cells not
exposed to stretch. Stretch was achieved by a computer-driven,
vacuum-operated Flexercell system (Flexcell) that has been described in
detail.27 This system was set to apply a defined vacuum
level (15 kPa) to provide a strain gradient across the culture plate
membrane bottom and attached cells; the gradient extends from zero in
the center to a maximum of 27% elongation at the periphery to achieve
an 18% average elongation. Release of the vacuum allows the membrane
to return to its original conformation, resulting in one complete cycle
per minute. Viable cell number was determined by hemocytometry and
trypan blue exclusion. Cell morphology was photographed with an Olympus
BHTU microscope equipped with a PM-10ADS photomicrographic system.
Organ Culture
To examine the effects of load on SMCs maintained in situ, we
used an organ culture system described in detail
elsewhere24 to study thoracic aorta with intact intimal
endothelial cells, medial SMCs, and adventitial
fibroblasts. Briefly, descending thoracic aortas were isolated under
sterile conditions from 200-g rats, and loose connective and fatty
tissue were carefully removed in M199 at 4°C with a stereomicroscope.
For each experiment, 25-mm lengths of aorta (one per animal) were
suspended horizontally from stainless steel wires in tissue culture
medium. Circumferential wall tension was provided by a second wire
connected to an adjustable weight (0.7 g/mm vessel length [submerged
tension]). This load was chosen to provide a preload 1.7- to 1.8-fold
in excess of that found to be optimal in contractile studies of
isolated rat aortic rings.24 Vessels in the control group
were suspended in culture medium in the absence of load. In some
experiments, we used a proline loop technique, which avoids mechanical
damage and proliferative stimulation of the underlying smooth muscle
media, to remove endothelial cells from vessels before
placement in organ culture.24 28 Serum-free medium (50%
Dulbecco's modified Eagle's medium and 50% F-12 containing 2.85
mg/mL insulin, 5 mg/L transferrin, 35.2 mg/L ascorbic acid, 6 µg/mL
selenium, and 2.5 mg/L penicillin/streptomycin/Fungizone [GIBCO-BRL])
was used in all organ culture experiments because in preliminary
experiments, load produced no differences in cultured SMCs in the
presence of serum and in serum-free medium (P. Ping and J.E.F.,
unpublished observations, 1993). The absence of serum also enabled us
to examine the effect of load without potentially confounding serum
growth factors. A single experimental time point consisted of eight
vessels (animals) each for load and no-load (control) groups to assure
adequate population sampling and provide sufficient tissue for
analysis. Consistent with other evidence, including
catecholamine contraction, that these vessels remain viable
in the organ culture environment for at least 48
hours,24 29 we found in preliminary studies of aorta
immediately after isolation ("fresh") and after 48 hours in
culture that total RNA (88±12% of fresh, n=5) and protein (84±17%
of fresh, n=5) content per millimeter of vessel length and ß-actin
levels (113±13% of fresh, n=3) remained constant.
Aortic Coarctation
We used hypertension produced by coarctation of the rat
suprarenal abdominal aorta as an in vivo model to test the effect of
load on SMC
1-AR expression. This approach also allowed
us to examine the effect of increased aortic pressure sustained over an
extended 30-day interval. At this time, the hypertension is associated
with increased angiotensin- and
catecholamine-dependent vascular tone.30 31 32 33
Coarctation of the aorta was produced in 180- to 200-g male
Sprague-Dawley rats using a modification of the techniques of Stanek et
al.32 The aorta proximal to the renal arteries was exposed
via a sterile abdominal approach. A sleeve of green plastic wrap was
sewn in place with a 7-0 silk suture around the aorta between the
celiac and superior mesenteric arteries to prevent growth of collateral
vessels. Size 0 silk suture was then tied between the vessels around
the aorta and a piece of 20-gauge needle tubing to completely occlude
blood flow. The tubing was then removed within several seconds. Sham
animals consisted of age-matched male littermates in which the
abdominal aorta was exposed without subsequent coarctation. Animals
received intraperitoneal penicillin and
streptomycin and intramuscular cefpiramide sodium (Sepatren, Samitomo
Pharmaceutical Co Ltd) and were housed three to a cage. Thirty
days after surgery, blood pressures were determined from the femoral
and carotid arteries with rats under ketamine (91 mg/mL) and
acepromazine (0.91 mg/mL) anesthesia. Animals were then
deeply anesthetized and transcardially perfused with 4°C
saline. The heart and vessel segments were taken between the aortic
arch and several millimeters above the site of constriction as well as
from 1 cm below coarctation to the bifurcation of the aorta. Identical
vessel segments were taken from sham animals. Left and right ventricles
and 5-mm segments of aortas 1 cm above and below the
stenosis/sham stenosis were reserved for determination
of tissue wet and dry (60°C, 4 hours) weights. This protocol was
approved by the Institutional Animal Care and Use Committee of the
University of North Carolina at Chapel Hill.
Protein and RNA Determinations
Total soluble protein concentration was determined by BCA assay
(Pierce Chemical). Total cellular RNA was extracted from cultured cells
using a modified acid guanidinium isothiocyanate/phenol/chloroform
method.24 In all organ culture experiments after a 48-hour
protocol (see "Results"), thoracic aortas were incubated in an
enzyme solution (Hanks' buffered salt solution [GIBCO-BRL], 100
µ/mL penicillin, 100 µg/mL streptomycin, 16 mmol/L sodium
bicarbonate, 1 mmol/L calcium chloride dihydrate, pH 7.2, 2 mg/mL
collagenase, 2 mg/mL soybean trypsin inhibitor,
and 13.5 U/mL elastase [enzymes from Worthington Biochemical
Corp]) for 23 minutes at 37°C in 95% air and 5% CO2.
The medial layer (100% SMCs) was then gently separated from the
adventitia (>95% fibroblasts23 24 ) with fine forceps
using a dissection microscope and 4°C tissue bath containing M199.
Endothelial cells were then removed or sham removed in
the already denuded group by gentle rubbing with a cotton-tipped
applicator. Medial segments were washed several times, frozen in liquid
nitrogen, and stored at -80°C. RNA was extracted within 2 weeks.
Vessel segments from stenosed and sham-stenosed animals were removed,
frozen in liquid nitrogen, and stored at -80°C. Vessels were ground
to powder at -80°C and homogenized in guanidinium
isothiocyanate solution, and RNA was extracted with
acid/phenol/chloroform as described above. RNA integrity and
concentration were assessed by gel electrophoresis and
spectrophotometry.
mRNA Measurement
We used RNase protection assays (RPAs) to measure mRNA levels.
Assay details, specificity of our RPAs, and
[32P]CTP-labeled probe construction have been previously
described.24 34 Briefly, a 709-bp fragment was cleaved
from the
1D cDNA and ligated into pGEM 4Z (Promega).
This fragment contains part of the coding region of the mRNA
corresponding to the putative third intracellular loop; DNA-dependent
RNA polymerase T7 produces a cRNA probe of 159 bases that protects 117
bp when hybridized to
1D mRNA. A 306-bp fragment of the
1B-AR cDNA between the putative second and third
intracellular loops ligated into pGEM 3Z yields a T7 transcribed cRNA
probe of 342 bases and a 306-bp protected hybrid. Plasmids containing
the 3' untranslated region of the
- and ß-actin mRNAs were
provided by G.K. Owens (University of Virginia), and RPAs were
developed for these transcripts to serve as controls.24 T7
produces a 303-base cRNA probe that protects 191 bp of the
-actin
mRNA. A plasmid containing 526 bases of the 3' untranslated mRNA
sequence was subcloned into pGEM-4, and the DNA-dependent RNA
polymerase SP6 was used to produce the ß-actin riboprobe. A plasmid
containing the partial rat cyclophilin cDNA (Ambion) was used in an RPA
as internal control for the
1D- and
1B-AR
RPAs in the coarctation studies. The cytosolic protein cyclophilin
(cyclosporin A binding protein) is ubiquitous in its tissue and
phylogenetic distribution, and the SMC content of its low-abundance
mRNA is refractory to many stimuli (including mechanical loading, see
"Results"), making it a useful internal control gene for
low-abundance target
1-AR mRNAs. Total cellular RNA was
incubated with riboprobes in solution, specific hybrids isolated with
RNase (either RNase ONE [
-actin RPA] or RNase A and T1
[Boehringer Mannheim]), and subjected to electrophoresis.
Gels were dried and exposed to autoradiographic film
(X-OMAT, Eastman Kodak). mRNA levels were measured according to film
densitometry (laser scanner [UMAX, UC630] and the Image program
(National Institutes of Health]). Exposure times were adjusted to
maintain film signal densities within a linear range.
Determination of Receptor Density
Receptor number was determined by radioligand
binding with methods described in detail previously.34
Briefly, aortic SMCs were washed twice with ice-cold phosphate-buffered
saline, scraped in 5 mmol/L Tris (pH 7.5) and 5 mmol/L EDTA
buffer, and homogenized and centrifuged at 18 000
rpm for 10 minutes at 4°C. The resulting pellets were frozen at
-80°C. Within 2 weeks, pellets were thawed on ice,
rehomogenized in 5 mmol/L Tris (pH 7.5) and 5
mmol/L EDTA buffer, and centrifuged at 18 000 rpm for 10
minutes at 4°C. The crude membrane was resuspended in incubation
buffer (5 mmol/L Tris [pH 7.5] and 5 mmol/L
MgCl2) and protein concentration determined by BCA assay.
Membranes were diluted to 1 mg/mL, and saturation binding was
determined with [3H]prazosin (New England Nuclear).
Nonspecific binding was determined in the presence of 10 µmol/L
phentolamine.
Statistics
Data are expressed as mean±SEM; "n" sizes
represent separate experiments, each from a separate cell line
in cell culture studies and pooled aortic segments from four to eight
aortas (one per animal) per time point in organ culture and in vivo
studies. Values were compared by ANOVA and/or Student's t
test for unpaired observations where appropriate (see figure legends).
Bmax and Kd values for
radioligand binding assays were determined by nonlinear
regression analysis (Graphpad). Differences were considered
significant at a value of P<.05.
| Results |
|---|
|
|
|---|
1D- and
1B-AR and Actin Isoform mRNA Expression and Cultured
Aortic SMC Growth
1D- or
1B-AR
mRNA levels (Fig 1
1D and
1B probes were hybridized with
total cellular RNA in the same reaction to examine the specificity of
load effects for either
1 subtype mRNA. Actin isoform
mRNA levels were also determined as controls for the specificity of any
response to cyclic cell deformation. ß-Actin mRNA content was similar
in SMCs subjected to mechanical load for 24 or 48 hours compared with
nonloaded time-matched control cells (Fig 1
-actin mRNA was also unaffected (Fig 1
-Actin
and ß-actin were determined in separate RPAs.
|
Since 48 hours of cyclic deformation induces DNA synthesis in vascular
smooth muscle,16 we determined cell number and total cell
protein and RNA contents in all experiments as measures of
proliferation and hypertrophy, respectively. Mechanical
loading did not alter cell number compared with nonloaded time-matched
control cells (Fig 2
). Cell viability remained at 98%
to 100% in all experiments. Total RNA and protein
levels per cell were also unaffected (Fig 2
). Cell alignment induced by
cyclic deformation was examined as a positive control for the effects
of deformation on SMCs. As noted by other
researchers,35 36 after 24 hours of cyclic deformation,
SMCs had realigned their long axes perpendicular to the axis of strain
(ie, in an annular fashion).
|
Effect of Load on Receptor Number
Membrane receptor density for total
1-ARs was
determined in cultured aortic SMCs subjected to cyclic loading for 48
hours. Total
1-AR binding to prazosin
(Bmax) was similar for control SMCs and loaded
cells (Table 1
). The antagonist dissociation
constant (Kd) was also similar for loaded versus
nonloaded control cells. At the Kd value,
nonspecific binding was 12±0.4% for control and 11±0.7% for loaded
cells.
|
Effect of Load on SMCs Maintained in Organ Culture
Expression of smooth musclespecific
-actin mRNA was increased
1.7-fold in the aortic medial layer after it was separated from intact
aorta that had been subjected to 48 hours of tonic load in organ
culture (Fig 3
). This effect was specific for the
expression of
-actin because, in contrast, load did not alter
1D,
1B, and ß-actin mRNA levels.
-Actin mRNA was similarly increased in loaded aorta from which
endothelial cells had been removed before placement in
organ culture compared with nonloaded media also denuded of
endothelial cells (2.1±0.2-fold increase, n=3
experiments, P<.05). Removal of endothelial
cells before organ culture did not significantly change mRNA levels for
ß-actin,
1D, or
1B in loaded media
compared with nonloaded time-matched controls. In agreement with
previous studies,24 SMC
-actin and
1B-AR
mRNA were not detected in adventitial fibroblast RNA (from 10 and 50
µg total RNA assayed, respectively). Load did not alter levels of
1D or ß-actin mRNA in adventitia (data not shown). No
changes in total protein, total RNA, or dry weight of the medial layer
(determined on a per millimeter of vessel media length basis) were
evidenced by aorta subjected to 48 hours of tonic load in organ culture
(Fig 3
).
|
Effects of Increased Load via Aortic Coarctation on SMCs In
Vivo
Thirty days after abdominal aortic coarctation, all measurements
(body weight, blood pressure, tissue wet weight) and the
thoracoabdominal aorta above the point of stenosis were
obtained from stenosed (hypertensive) and sham-stenosed (normotensive)
rats. The abdominal aorta was also taken beginning 1 cm below the site
of ligation (normotensive in both stenosed and sham-operated animals).
Carotid artery pressure was 61% higher in stenosed rats, and femoral
artery pressure was identical in both stenosed and sham-operated rats,
as expected30 31 32 33 (Table 2
). Whereas right
ventricular wet weight was not affected by aortic
stenosis, left ventricular wet weight was
significantly increased by 48%. To document any vascular hypertrophic
effect of the hypertension, we determined aortic mass as a percentage
of total body weight (Fig 4
). Wet and dry weights from
the suprarenal aorta of stenosed rats were significantly higher than
those of sham-stenosed (control) animals (Fig 4
). Interestingly, aortic
wet and dry weights of the subrenal aorta below the constriction were
also significantly greater in stenosed rats than control rats. Total
protein and RNA per millimeter of vessel from stenosed suprarenal aorta
were increased 1.3- and 1.5-fold, respectively, over sham vessels,
whereas subrenal aorta had comparable total protein and RNA content in
both stenosed and sham animals (Fig 4
). These results indicate that
aorta exposed to chronic hypertension hypertrophied in association with
an increase in cell size and/or cell number. In contrast,
hypertrophy seen in the normotensive subrenal aorta of
stenosed animals (Fig 4
) may reflect nonprotein increases in
carbohydrate and/or lipid. This subrenal hypertrophy
suggests that a humoral factor or factors, to which aorta both above
and below the site of constriction was exposed, can increase vascular
wall mass in the absence of increased wall load.
|
|
To differentiate the effects of pressure per se from that of
humoral factors on mRNA expression, we performed RPAs using RNA from
subrenal aorta exposed to normal pressure as well as suprarenal aorta
exposed to high pressure in stenosed rats and compared them with
results from sham-stenosed (control) vessels. Cyclophilin mRNA was not
significantly different in all four vessel segment groups and was
therefore used as an internal assay control to normalize mRNAs in each
1-AR and
-actin RPA. Besides load, we have also found
that cyclophilin mRNA is unaffected by exposure of cultured aortic SMCs
to 4 to 48 hours of norepinephrine (1 µmol/L),
angiotensin II (1 nmol/L to 1 µmol/L),
hypoxia (21 versus 150 mm Hg PO2),
estrogen (10 nmol/L), dexamethasone (10 nmol/L), cGMP
(25 nmol/L), insulin (50 mmol/L), KCl (40 mmol/L), epidermal
growth factor (100 ng/mL), retinoic acid (10 nmol/L), endothelin-1 (10
nmol/L), histamine (100 nmol/L), prostaglandin
F2
(100 nmol/L), serotonin
(10 µmol/L), and thrombin (10 nmol/L) (unpublished results,
1996). There was no difference in expression of
1D-AR
mRNA in stenosed versus sham-stenosed (control) aorta, both from
suprarenal as well as subrenal aorta (Fig 5
).
1B-AR mRNA was not altered in suprarenal aorta, but
levels in subrenal stenosed aorta were decreased to 68±14% of those
in sham-stenosed aorta. This suggests the presence of a humoral factor
or factors in the stenosed animals that favors reduction of
1B expression in aorta protected from hypertension.
|
-Actin mRNA expression in aorta exposed to hypertension was
increased twofold, whereas
-actin mRNA in subrenal aorta was not
different from that in sham-stenosed aorta (Fig 5
). Thus, in agreement
with the organ culture model, pressure alone appears capable of
increasing
-actin expression. ß-Actin mRNA was unaffected in all
groups.
| Discussion |
|---|
|
|
|---|
-AR subtypes may mediate SMC constriction of
arteries, arterioles, venules, and veins.2 5 6 7 8 The
declining pressure gradient, and thus SMC load, experienced across
these vascular segments, together with evidence that increased load may
alter
1-AR expression,9 10 15 suggests that
load may influence
1-AR expression by SMCs. We used
three modelscell culture, organ culture, and in vivo aortic
stenosisto examine the effects of load on
1D-
and
1B-AR expressions. Mechanical loading of early
passage cultured aortic SMCs over 48 hours did not alter
1D- or
1B-AR mRNA expression or
1 receptor density. The absence of effect was not due to
the cell culture environment because 48 hours of load also failed to
affect expression of these transcript levels in intact aortic media
maintained in organ culture. In vivo suprarenal aortic coarctation,
which we used to elevate pressure in the aorta above the point of
stenosis for a more prolonged period (30 days), also did not
alter
1D- or
1B-AR mRNA expression in the
hypertensive aorta. The lack of changes in expression was not due to
failure of the SMCs to experience load in these in vitro, in situ, and
in vivo studies. Load increased
-actin expression in the in situ and
in vivo (and tended to in the cell culture) models and caused the
expected load-induced realignment of cultured cells.35 36
The absence of effect also cannot be attributed to complications
associated with proliferation or hypertrophy of SMCs. No
changes in proliferation were induced in cultured cells, and no cell
hypertrophy (that is, no concomitant increase in both RNA
and protein levels per cell or millimeter of vessel
length24 ) or changes in ß-actin expression were detected
in cultured cells or organ cultured aortic wall media (where dry weight
was also unaffected). In prolonged coarctation hypertension, the
hypertrophy evidenced by both the hypertensive and
normotensive aorta, which were similar in magnitude, was not correlated
with a change in
1B or
1D expression.
Although these studies were confined to aortic SMCs, in two other
experiments, each conducted on separate cell lines of passage 5
cultured rat vena caval SMCs, cyclic load over 48 hours also had no
effect on mRNA levels for
1B,
1D,
-actin, or ß-actin nor on cell number, per-cell protein, or RNA
(data not shown). Thus, these results indicate that the mechanical load
imposed on SMCs, at least over 2 to 30 days, is not a direct
determinant of
1B- and
1D-AR
expressions.
A limitation of our radioligand binding results is that
only total
1-AR number was measured and only in the
cultured cell model. This is because of inadequate tissue quantity for
binding studies obtained from the approximately 100 rats used for each
of the organ culture and in vivo studies as well as the absence of
suitable antagonists or antibodies available for clear
separation of
1B and
1D subtypes in
binding or immunodetection studies of cell types such as SMCs with a
characteristic very low total
1-AR
density.34 It should also be noted that we did not examine
1A-AR expression in the present study because we are
unable to detect
1A mRNA in aortic or vena caval SMC
cultures in early passage (passages 2 through 5) using a sensitive
1A RPA against even 100 µg RNA (J.E.F. et al,
unpublished results, 1996). Whether SMCs in the intact aorta express
1A-ARs remains unclear because the few previous
investigations have not distinguished between SMC,
endothelial cell, and adventitial fibroblast sources of
RNA extracted from whole vessels. It remains possible, even though mRNA
levels did not change, that opposing changes in
1B- and
1D-AR densities may have occurred without a change in
overall
1-AR number as reflected by
[3H]prazosin binding. Also noteworthy are differences in
the mechanical loads and duration of presentation in the
three models we used. Loading was phasic in cell culture and tonic in
organ culture, and both phasic and tonic increases over control were
produced by coarctation hypertension. In the latter study, pulse
pressures from paired carotid and femoral determinations in the same
animals were 95±10 mm Hg in the suprarenal and 13±2 mm Hg
in the subrenal aorta of coarctation animals (n=12), and 28±4
mm Hg in the suprarenal and 49±3 mm Hg in the subrenal aorta of
sham-stenosed animals (n=6). However, despite these differences in the
three models, increased load had no effect on
1B or
1D expression.
In the subrenal normotensive aorta of coarcted animals, no change in
1D-AR mRNA expression was detected, but
1B mRNA levels were decreased. Pulse pressure in the
subrenal aorta was 74% lower and in the suprarenal aorta 339% higher
compared with that in sham-coarcted control segments. These differences
may suggest that reduced phasic load in the subrenal aorta below the
stenosis decreases
1B-AR expression. However,
the lack of an increase in
1B mRNA in the suprarenal
aorta, together with no effect of load in cell or organ culture
experiments, argues against a role for SMC load in
1B-
or
1D-AR expression.
A perhaps more likely mechanism for the decrease in
1B mRNA in the subrenal aorta may involve an interaction
of load with a humoral factor present in in vivo hypertension.
Plasma renin activity increases within minutes after a reduction in
renal perfusion pressure37 and after aortic
coarctation.38 While renin levels return to normal or
near-normal levels in 1 to 2 weeks, hypertension persists above the
point of stenosis in association with increased
angiotensin and sympathetic dependence.33 38
Since mean pressure was unaffected below the stenosis, the
decrease in
1B-AR expression evidenced therein may be
due to the presence of a circulating factor or factors such as
angiotensin. Although speculative, the increase in pressure
above the stenosis may oppose such a humoral-dependent
reduction in
1B mRNA levels. The decrease in
1B mRNA expression was specific since no changes in
cyclophilin mRNA were detected in the same assay and no effects on
1D mRNA expression levels were observed. Besides a
possible role for angiotensin II to induce selective
downregulation of
1B expression, differences in the
nature of the hypertrophy above versus below the
coarctation (see below) could also be involved in the decrease in
1B-AR mRNA below the coarctation.
Although not the main focus of this study, we obtained new findings
regarding whether load directly influences growth of SMCs in the intact
vascular wall. Although substantial correlative evidence links the
degree of blood pressure elevation with the amount of vascular
hypertrophy,39 there is little evidence that
mechanical load directly causes medial SMC hypertrophy.
Application of load over 48 hours did not result in changes in growth
of postconfluent, quiescent cultured SMCs or intact aortic media in
organ culture. Holycross et al29 also did not find an
increase in protein or DNA synthesis in rat aortic rings subjected to
0.6 g/mm tension versus no load over 16 hours in organ culture, in
which contractile responses to angiotensin II and
phenylephrine were maintained. However, Bardy et
al22 used an elegant organ culture model and found that
total protein synthesis in the medial layer of the rabbit aorta
increased sixfold, when pressurized to 150 mm Hg for 3 days,
over basal protein synthesis levels observed at 0 and 80
mm Hg but only when the vessels were maintained in the presence of
serum. In our studies, the absence of serum or a shorter duration of
loading (2 days) may have prevented detection of an increase in vessel
wall protein, RNA, or dry weight, although SMC
-actin was increased.
We did observe that a prolonged increase in load by aortic coarctation
increased wet and dry weights and total protein and RNA for a given
amount of vessel length above the point of stenosis. This may
reflect the increase in cell size and absence of cell proliferation
noted by other researchers,40 although hyperplasia was
detected by Owens and Reidy41 in a rat aortic coarctation
model in which hypertension was, however, not sustained. Wet and dry
weights of the subrenal aorta in stenosed animals also increased but
without changes in RNA or protein, indicating wall
hypertrophy, possibly from increased carbohydrate and/or
lipid in the extracellular matrix. This presence of wall
hypertrophy below the coarctation is supported by similar
reports of structural remodeling of the vasculature and an increase in
the minimal resistance below the stenosis.42 43
Interestingly, fibronectin mRNA and protein were increased in the aorta
both above and below coarctation when examined 14 days after surgery,
whereas laminin was increased and chondroitin sulfate decreased only
above the stenosis.44 Other studies with prolonged
angiotensin infusion confirm a selective increase in
fibronectin expression and vascular hypertrophy that are
not solely dependent on an increase in pressure.45 46 47
Future studies concerning alterations in wall composition are needed
that consider both humoral and pulse-pressure
differences48 as potential influences in these changes
above versus below stenosis.
Vascular hypertrophy associated with hypertension has
been postulated to result from direct load-induced alterations in the
expression of certain growth factors. Wilson et al16
detected increased PDGF-A expression, thymidine incorporation, and cell
number in passages 16 through 29 SMCs of the R22D cell line exposed to
48 hours of phasic loading. However, increased PDGF levels have been
associated with reduced
-actin mRNA levels in SMCs.26
Moreover, in the present study,
-actin mRNA increased in organ
cultured SMCs exposed to tonic load and in aorta exposed to
hypertension in vivo. This is the first demonstration of a direct
effect of load to increase
-actin expression in SMCs both in vitro
and in vivo. Interestingly, smooth muscle
-actin mRNA is reexpressed
by adult rat myocardium 24 hours after aortic
coarctationinduced load.49 Furthermore, the
-actin
increase we observed does not require concomitant growth since it
occurred in organ culture and coarctation models to the same degree in
the absence versus presence of vascular wall hypertrophy.
Although these increases in
-actin mRNA require confirmation at the
protein level, SMC expression of collagen50 51 and
expression of cytoskeletal proteins in skeletal muscle52
are also induced by a maintained increase in mechanical load. These
effects have been postulated to oppose the increased stress placed on
the cells, and our observed increase in
-actin mRNA may underlie a
similar adaptive response.
In summary, no evidence was obtained suggesting that load is a
direct determinant of
1B- or
1D-AR
expression by SMCs. We have also not located the presence of the
putative shear-sensitive response element21 in the known
DNA sequence flanking the coding region of the rat
1B
and
1D genes. Load does appear to increase
-actin
gene expression and wall hypertrophy, but in coarctation
hypertension, the normotensive vasculature appears to also undergo
hypertrophy that is, however, different in composition.
Whether these differences or the observed decrease in
1B-AR mRNA in this region and absence of its
downregulation in the hypertensive aorta are involved in the increase
in catecholamine sensitivity reported in both the
suprarenal and subrenal coarcted aorta53 54 remain to be
determined. Interestingly, unlike the increased
norepinephrine sensitivity of the subrenal aorta, which was
abolished after endothelial cell removal, in the
suprarenal aorta, increased sensitivity was specific for the SMCs and
unaffected by endothelial cell
inactivation.54
| Acknowledgments |
|---|
| Footnotes |
|---|
Received August 20, 1996; first decision October 15, 1996; accepted November 25, 1996.
| References |
|---|
|
|
|---|
1-Adrenergic receptor subtypes: molecular structure,
function and signaling. Circ Res. 1996;78:737-749.
2.
Leech CJ, Faber JE. Different
-adrenoceptor
subtypes mediate constriction of arterioles and venules.
Am J Physiol. 1996;270:H710-H722.
3.
Muldowney SM, Faber JE. Preservation of venular
but not arteriolar smooth muscle
-adrenoceptor sensitivity during
reduced blood flow. Circ Res. 1991;69:1215-1225.
4.
Leech CJ, Faber JE. Differential sensitivity of
venule and arteriole
-adrenergic receptor constriction to inhibition
by hypoxia: role of receptor subtype and coupling
heterogeneity. Circ Res. 1996;78:1064-1074.
5.
Buckner SA, Oheim K, Morse P, Knepper S, Hancock AA,
Kerwin JF. Functional and radioligand binding
evidence for and
1D-adrenoceptor subtype mediating
contraction in the rat aorta. FASEB J. 1995;9:A105.
Abstract.
6.
Goetz AS, King HK, Ward SD, True TA, Rimele TJ, Saussy
DL. BMY 7378 is a selective antagonist of the D
subtype of
1-adrenoceptors. Eur J
Pharmacol. 1995;272:R5-R6.[Medline]
[Order article via Infotrieve]
7.
Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy
DL, Perez DM. The specific contribution of the novel alpha-1D
adrenoceptor to the contraction of vascular smooth muscle.
J Pharmacol Exp Ther. 1995;275:1583-1589.
8.
Sayet I, Neuilly G, Rakotoarisoa L, Mironneau J,
Mironneau C. Rat vena cava
1B-adrenoceptors:
characterization by [3H] prazosin binding and contraction
experiments. Eur J Pharmacol. 1993;246:275-281.[Medline]
[Order article via Infotrieve]
9.
Uemura N, Vatner DE, Shen Y, Wang J, Vatner SF.
Increased
1-adrenergic vascular sensitivity during
development of hypertension in conscious dogs. Am J
Physiol. 1993;264:H1259-H1268.
10.
Michel MC, Siepmann F, Buscher R, Philipp T, Brodde
O. Ontogenesis of sympathetic responsiveness in spontaneously
hypertensive rats, I: renal
1-, and
2-,
and ß-adrenergic receptors and their signaling.
Hypertension. 1993;22:169-177.
11.
Woodcock EA, Johnston CI. Changes in tissue
alpha- and beta-adrenergic receptors in renal hypertension in the
rat. Hypertension. 1980;2:156-161.
12.
Hanna MK, Khairallah PA. Alterations of
myocardial
1-adrenergic receptors in hypertensive cardiac
hypertrophy in the rat. Arch Int Pharmacodyn
Ther. 1986;283:80-93.[Medline]
[Order article via Infotrieve]
13.
Eid H, de Champlain J. Increased inositol
monophosphate production in cardiovascular
tissues of DOCA-salt hypertensive rats.
Hypertension. 1988;12:122-128.
14.
McCaughran JA Jr, Juno CJ, Friedman R. Pre- and
neonatal exposure of the Dahl rat to NaCl: development and regional
distribution of myocardial
1-adrenergic and cholinergic receptor
sites. J Auton Nerv Syst. 1986;16:137-152.[Medline]
[Order article via Infotrieve]
15. Karliner JS, Barnes P, Brown M, Dollery C. Chronic heart failure in the guinea pig increases cardiac alpha 1- and beta-adrenoceptors. Eur J Pharmacol. 1980;67:115-118.[Medline] [Order article via Infotrieve]
16.
Wilson E, Qing M, Sudhir K, Weiss RH, Ives HE.
Mechanical strain induces growth of vascular smooth muscle cells via
autocrine action of PDGF. J Cell Biol. 1993;123:741-747.
17.
Komuro I, Kaida T, Shibazaki Y, Kurabayashi M, Katoh Y,
Hoh E, Takaku F, Yazaki Y. Stretching cardiac myocytes
stimulates protooncogene expression. J Biol
Chem. 1990;265:3595-3598.
18.
Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M,
Hoh E, Takaku F, Yazaki Y. Mechanical loading stimulates cell
hypertrophy and specific gene expression in cultured rat
cardiac myocytes: role of protein kinase C activation.
J Biol Chem. 1991;266:1265-1268.
19.
Yamazaki T, Tobe K, Hoh E, Maemura K, Kaida T, Komuro
I, Tamemoto H, Kadowaki T, Nagai R, Yazaki Y. Mechanical loading
activates mitogen-activated protein kinase and S6
peptide kinase in cultured rat cardiac myocytes. J
Biol Chem. 1993;268:12069-12076.
20.
Shyy JY, Lin MC, Han J, Lu Y, Petrime M, Chien
S. The cis-acting phorbol ester
`12-O-tetradecanoylphorbol 13-acetate'-responsive
element is involved in shear stress-induced monocyte chemotactic
protein 1 gene expression. Proc Natl Acad Sci
U S A. 1995;92:8069-8073.
21. Khachigian LM, Resnick N, Gimbrone MAJ, Collins T. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest. 1995;96:1169-1175.
22.
Bardy N, Karillon GJ, Merval R, Samuel J-L, Tedgui
A. Differential effects of pressure and flow on DNA and protein
synthesis and on fibronectin expression by arteries in a novel organ
culture system. Circ Res. 1996;79:70-78.
23.
Ping P, Faber JE. Characterization of
-adrenoceptor gene expression in arterial and venous
smooth muscle. Am J Physiol. 1993;265:H1501-H1509.
24.
Chen LQ, Xin X, Eckhart AD, Yang N, Faber JE.
Regulation of vascular smooth muscle growth by
1-adrenoceptor subtypes in vitro and in situ.
J Biol Chem. 1995;270:30980-30988.
25.
Monical PL, Owens GK, Murphy RA. Expression of
myosin regulatory light-chain isoforms and regulation of
phosphorylation in smooth muscle. Am
J Physiol. 1993;264:C1466-C1472.
26.
Corjay MH, Thompson MM, Lynch KR, Owens GK.
Differential effect of platelet-derived growth factor versus
serum-induced growth on smooth muscle
-actin and nonmuscle ß-actin
mRNA expression in cultured rat aortic smooth muscle cells.
J Biol Chem. 1989;264:10501-10506.
27. Banes AJ, Gilbert J, Taylor D, Monbureau O. A new vacuum-operated stress-providing instrument that applies static or variable duration cyclic tension or compression to cells in vitro. J Cell Sci. 1985;75:35-42.[Abstract]
28.
Fingerle J, Au YP, Clowes AW, Reidy MA. Intimal
lesion formation in rat carotid arteries after
endothelial denudation in absence of medial
injury. Arteriosclerosis. 1990;10:1082-1087.
29. Holycross BJ, Peach MJ, Owens GK. Angiotensin II stimulates increased protein synthesis, not increased DNA synthesis, in intact rat aortic segments, in vitro. J Vasc Res. 1993;30:80-86.[Medline] [Order article via Infotrieve]
30.
Bagby SP, Baur GM, Gray DK. Canine neonatally
induced coarctation hypertension in the second year.
Hypertension. 1983;5:328-335.
31. van Way CWI, Michelakis AM, Anderson WJ, Manlove A, Oates IA. Studies of plasma renin activity in coarctation of the aorta. Ann Surg. 1976;183:229-238.[Medline] [Order article via Infotrieve]
32.
Stanek KA, Coleman TG, Murphy WR. Overall
hemodynamic pattern in coarctation of the abdominal
aorta in conscious rats. Hypertension. 1987;9:611-618.
33.
Overbeck HW. Pressure-dependent increases in
vascular resistance in hypertension: role of sympathoadrenergic
influences. Hypertension. 1980;2:780-786.
34.
Eckhart AD, Zhu Z, Arendshorst WJ, Faber JE.
Oxygen modulates
1B-adrenoceptor gene expression by
arterial but not venous vascular smooth muscle.
Am J Physiol. 1996;271:H1599-H1608.
35. Sumpio BE, Banes AJ. Response of porcine aortic smooth muscle cells to cyclic tensional deformation in culture. J Surg Res. 1988;44:696-701.[Medline] [Order article via Infotrieve]
36.
Davis MG, Ali S, Leikauf GD, Dorn GWI. Tyrosine
kinase inhibition prevents deformation-stimulated vascular smooth
muscle growth. Hypertension. 1994;24:706-713.
37. Faber JE, Brody MJ. Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats. Hypertension. 1983;5(suppl I):I-155-I-164.
38. Yagi S, Kramsch DM, Madoff IM, Hollander W. Plasma renin activity in hypertension associated with coarctation of the aorta. Am J Physiol. 1968;215:605-610.
39. Owens GK. Role of contractile agonists in growth regulation of vascular smooth muscle cells. In: Cox RH, ed. Cellular and Molecular Mechanisms in Hypertension. New York, NY: Plenum Publishing Corp; 1991:71-79.
40. Olivetti G, Anversa P, Melissari M, Loud AV. Morphometry of medial hypertrophy in the rat thoracic aorta. Lab Invest. 1980;42:559-565.[Medline] [Order article via Infotrieve]
41.
Owens GK, Reidy MA. Hyperplastic growth response
of vascular smooth muscle cells following induction of acute
hypertension in rats in aortic coarctation. Circ
Res. 1985;57:695-705.
42.
Liu JL, Bishop SP, Overbeck HW. Morphometric
evidence for non-pressure-related arterial wall thickening
in hypertension. Circ Res. 1988;62:1001-1010.
43.
Nolla-Panades J. Hypertension and
increased hindlimb vascular reactivity in experimental coarctation of
the aorta. Circ Res. 1963;12:3-9.
44.
Lipke DW, McCarthy KJ, Elton TS, Arcot SS, Oparil S,
Couchman JR. Coarctation induces alterations in basement
membranes in the cardiovascular system.
Hypertension. 1993;22:743-753.
45. Scott-Burden T, Hahn WA, Resnick TJ, Buhler FR. Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol. 1990;16(suppl 4):S36-S41.
46.
Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson
VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin
II causes vascular hypertrophy in part by a non-pressor
mechanism. Hypertension. 1991;17:626-635.
47. Himeno H, Crawford DC, Hosoi M, Chobanian AV, Brecher P. Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension. 1994;23(part 2):823-826.
48.
Baumbach GL. Effects of increased pulse pressure
on cerebral arterioles. Hypertension. 1996;27:159-167.
49. Black FM, Packer SE, Parker TG, Michael LH, Roberts R, Schwartz RJ, Schneider MD. The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load. J Clin Invest. 1991;88:1581-1588.
50.
Sumpio BE, Banes AJ, Link WG, Johnson GJ.
Enhanced collagen production by smooth muscle cells during
repetitive mechanical stretching. Arch Surg. 1988;123:1233-1236.
51. Sottiurai VS, Kollros P, Glagor S, Zarins CK, Mathews MB. Morphologic alteration of cultured arterial smooth muscle cells by cyclic stretching. J Surg Res. 1983;35:490-497.[Medline] [Order article via Infotrieve]
52.
Goldspink G, Scutt A, Loughna PT, Wells DJ, Jaenicke T,
Gerlach GF. Gene expression in skeletal muscle in response to
stretch and force generation. Am J Physiol. 1992;262:R356-R363.
53. Husken BCP, Mertens MJF, Pfaffendorf M, Van Zwieten PA. The influence of coarctation hypertension on the pharmacodynamic behavior of rat isolated conduit vessels. Blood Pressure. 1994;3:255-259.[Medline] [Order article via Infotrieve]
54.
Bell DR, Bohr DF. Endothelium in
functional aortic changes of coarctation hypertension.
Am J Physiol. 1991;260:H1187-H1193.
This article has been cited by other articles:
![]() |
H. Zhang and S. A. Fisher Conditioning Effect of Blood Flow on Resistance Artery Smooth Muscle Myosin Phosphatase Circ. Res., March 16, 2007; 100(5): 730 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Augustus, J. Buchanan, T.-S. Park, K. Hirata, H.-l. Noh, J. Sun, S. Homma, J. D'armiento, E. D. Abel, and I. J. Goldberg Loss of Lipoprotein Lipase-derived Fatty Acids Leads to Increased Cardiac Glucose Metabolism and Heart Dysfunction J. Biol. Chem., March 31, 2006; 281(13): 8716 - 8723. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hosoda, T.-a. Koshimizu, A. Tanoue, Y. Nasa, R. Oikawa, T. Tomabechi, S. Fukuda, H. Shinoura, S. Oshikawa, S. Takeo, et al. Two {alpha}1-Adrenergic Receptor Subtypes Regulating the Vasopressor Response Have Differential Roles in Blood Pressure Regulation Mol. Pharmacol., March 1, 2005; 67(3): 912 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. M. Wesselman, A. D. Dobrian, S. D. Schriver, and R. L. Prewitt Src Tyrosine Kinases and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases Mediate Pressure-Induced C-Fos Expression in Cannulated Rat Mesenteric Small Arteries Hypertension, March 1, 2001; 37(3): 955 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Clements and J. E. Faber Mechanical Load Opposes Angiotensin-Mediated Decrease in Vascular {alpha}1-Adrenoceptors Hypertension, May 1, 1997; 29(5): 1165 - 1172. [Abstract] [Full Text] |
||||
![]() |
P Lindahl, L Karlsson, M Hellstrom, S Gebre-Medhin, K Willetts, J. Heath, and C Betsholtz Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development Development, January 10, 1997; 124(20): 3943 - 3953. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |